Pneumococcal Vaccine: Handling the change in product manufacturer and presentation

Summary guidance for national authorities and immunization programme managers for the switch from GlaxoSmithKline Biologicals SA Synflorix® (PCV 10) to Pfizer Prevenar13® vaccine (PCV 13)

World Health Organization
2017

Added by: Géraldine Nemrod
Added on: 28 October, 2020
Hits: 448